A drug industry executive fainted during a press conference in the Oval Office where President Donald Trump was announcing an agreement with drugmakers to lower obesity drug prices.
The event was interrupted when Gordon Findlay, Novo Nordisk's global brand director, collapsed. This occurred as David Ricks, CEO of Eli Lilly, was speaking and noticed Findlay's condition, asking,
“Are you okay? Gordon, are you okay?”
Dr. Mehmet Oz, the Administrator for the Centers for Medicare & Medicaid Services, immediately assisted Findlay as he fell to his knees. Health and Human Services Secretary was also present in the room at the time.
The press conference focused on a new deal with Eli Lilly and Novo Nordisk to expand insurance coverage and reduce prices for their obesity treatments, including Zepbound and Wegovy.
Author’s summary: During a White House press event on lowering obesity drug prices, a Novo Nordisk executive collapsed, prompting immediate medical aid and a temporary pause before the conference continued.